Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alkermes shares rise 6% on Biogen multiple sclerosis drug partnership
Alkermes shares rise 6% on Biogen multiple sclerosis drug partnership
Alkermes shares rise 6% on Biogen multiple sclerosis drug partnership
Submitted by
admin
on November 27, 2017 - 9:10am
Source:
Marketwatch
News Tags:
Alkermes
Biogen
MS
multiple sclerosis
ALKS 8700
Headline:
Alkermes shares rise 6% on Biogen multiple sclerosis drug partnership
Do Not Allow Advertisers to Use My Personal information
